COM:INVENTIVAPHARMA
Inventiva Pharma
- Stock
Last Close
2.58
21/11 16:35
Market Cap
125.95M
Beta: -
Volume Today
19.73K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 502.69K - | 478.73K 4.77% | 476.16K 0.54% | 472.50K 0.77% | 441.56K 6.55% | 398.50K 9.75% | 353.50K 11.29% | 356K 0.71% | 382.50K 7.44% | 186.50K 51.24% | ||
average payables | 1.78M - | 2.75M 54.38% | 3.99M 45.13% | 4.87M 22.21% | 6.88M 41.12% | 7.93M 15.34% | 7.21M 9.13% | 10.76M 49.33% | 16.98M 57.77% | 9.68M 43.00% | ||
average receivables | 2.36M - | 3.95M 67.02% | 6.42M 62.50% | 7.50M 16.91% | 10.10M 34.68% | 12.75M 26.19% | 12.84M 0.68% | 12.55M 2.20% | 10.46M 16.64% | 4.67M 55.36% | ||
book value per share | 5.88 - | 5.14 12.72% | 4.26 16.96% | 2.27 46.76% | 4.13 81.73% | 3.00 27.31% | 1.76 41.31% | 3.28 86.55% | 2.27 30.89% | |||
capex per share | -0.19 - | -0.13 32.71% | -0.10 24.97% | -0.01 85.01% | -0.03 90.45% | -0.03 3.11% | -0.01 78.37% | -0.01 49.07% | -0.01 58.16% | |||
capex to depreciation | -1.39 - | -1.05 24.28% | -0.74 29.18% | -0.14 81.43% | -0.30 117.62% | -0.24 21.23% | -0.09 63.67% | -0.15 79.57% | 0.41 368.07% | -0.33 179.69% | ||
capex to operating cash flow | 0.12 - | 0.09 27.15% | 0.07 20.66% | 0.02 77.87% | 0.03 64.13% | 0.02 36.25% | 0.00 70.17% | 0.01 99.36% | 0.01 17.45% | 0.01 11.37% | ||
capex to revenue | -0.63 - | -0.39 37.19% | -0.20 49.47% | -0.02 87.86% | -0.07 172.01% | -0.17 161.61% | -0.02 88.68% | -0.78 3,939.01% | -0.13 83.78% | -0.05 63.82% | ||
cash per share | 1.35 - | 1.71 26.74% | 2.25 31.85% | 1.58 29.86% | 3.81 140.82% | 2.76 27.48% | 1.52 44.79% | 3.34 118.95% | 2.44 27.01% | |||
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 181.01 - | 356.79 97.12% | 351.11 1.59% | 314.76 10.35% | 383.97 21.99% | 1.52K 296.92% | 633.87 58.41% | 13.27K 1,993.09% | 1.01K 92.40% | 280.01 72.23% | ||
debt to assets | 0.00 - | 0.00 22.42% | 0.01 706.72% | 0.01 11.47% | 0.01 49.53% | 0.03 325.81% | 0.04 33.70% | 0.10 158.54% | 0.08 13.05% | 0.30 258.67% | ||
debt to equity | 0.00 - | 0.00 25.38% | 0.02 704.69% | 0.02 7.65% | 0.01 57.13% | 0.04 374.89% | 0.05 41.99% | 0.12 134.68% | 0.11 4.46% | 0.76 566.52% | ||
dividend yield | ||||||||||||
earnings yield | -0.08 - | -0.09 5.03% | -0.10 17.74% | -0.05 49.11% | -0.23 348.96% | -0.29 24.31% | -0.35 20.23% | -0.08 77.25% | -0.11 35.52% | |||
enterprise value | 72.70M - | 69.02M 5.05% | 64.16M 7.05% | 110.78M 72.66% | 14.98M 86.48% | 60.95M 306.93% | 52.58M 13.74% | 304.58M 479.28% | 383.40M 25.88% | -52.22M 113.62% | -26.90M 48.49% | |
enterprise value over ebitda | -7.03 - | -6.02 14.40% | -4.90 18.51% | -11.18 128.07% | -0.80 92.86% | -1.97 146.41% | -1.91 2.75% | -10.25 435.95% | -8.22 19.79% | 0.91 111.12% | -1.54 268.10% | |
ev to operating cash flow | -4.54 - | -4.67 2.79% | -4.59 1.70% | -7.45 62.47% | -0.88 88.18% | -1.78 102.26% | -1.85 3.89% | -9.96 437.88% | -8.05 19.15% | 1.16 114.44% | 0.33 71.64% | |
ev to sales | 23.72 - | 21.03 11.37% | 13.16 37.40% | 11.73 10.89% | 2.30 80.41% | 19.07 730.00% | 7.51 60.59% | 818.76 10,797.29% | 91.42 88.83% | -4.29 104.69% | -1.54 64.15% | |
free cash flow per share | -1.79 - | -1.60 10.31% | -1.49 7.01% | -0.96 35.68% | -1.12 17.16% | -1.69 50.63% | -1.21 28.29% | -0.91 24.87% | -1.23 34.88% | |||
free cash flow yield | -0.21 - | -0.19 10.31% | -0.17 7.01% | -0.11 35.68% | -0.24 112.07% | -0.30 27.04% | -0.33 9.82% | -0.08 76.47% | -0.10 34.65% | |||
graham net net | -1.31 - | -0.18 86.02% | 0.85 563.72% | 1.15 34.79% | 3.48 203.39% | 2.37 31.98% | 1.26 46.94% | 2.82 124.43% | 1.82 35.64% | |||
graham number | 9.70 - | 9.29 4.25% | 9.19 1.12% | 4.78 47.95% | 10.15 112.30% | 10.51 3.51% | 7.13 32.12% | 8.30 16.42% | 8.04 3.14% | |||
income quality | 2.24 - | 1.97 12.05% | 1.58 19.69% | 2.11 33.10% | 0.99 53.22% | 1.02 3.11% | 0.94 7.62% | 0.91 3.20% | 0.96 5.46% | 0.83 13.73% | ||
intangibles to total assets | 0.02 - | 0.03 31.47% | 0.04 29.95% | 0.04 8.23% | 0.02 42.77% | 0.02 20.40% | 0.02 11.51% | 0.01 68.78% | 0.01 6.21% | 0.00 22.43% | 0 100% | |
interest coverage | -19.79K - | -4.59K 76.83% | -2.56K 44.19% | -1.72K 32.60% | -3.93K 128.11% | -8.31K 111.29% | -10.10K 21.54% | -450.27 95.54% | -19.78 95.61% | -80.78 308.43% | ||
interest debt per share | 0.02 - | 0.01 33.30% | 0.07 555.56% | 0.04 42.50% | 0.03 22.18% | 0.11 242.06% | 0.09 16.70% | 0.39 339.35% | 0.33 17.19% | |||
inventory turnover | ||||||||||||
invested capital | 0.00 - | 0.00 25.38% | 0.02 704.69% | 0.02 7.65% | 0.01 57.13% | 0.04 374.89% | 0.05 41.99% | 0.12 134.68% | 0.11 4.46% | 0.76 566.52% | ||
market cap | 86.06M - | 86.06M 0% | 86.06M 0% | 135.02M 56.90% | 73.55M 45.53% | 115.44M 56.96% | 86.32M 25.23% | 397.01M 359.94% | 459.83M 15.82% | |||
net current asset value | -11.91M - | -121.50K 98.98% | 10.81M 8,996.84% | 28.11M 160.06% | 56.86M 102.27% | 53.42M 6.06% | 33.31M 37.65% | 105.29M 216.12% | 82.46M 21.68% | 35.85M 56.52% | ||
net debt to ebitda | 1.29 - | 1.49 14.93% | 1.67 12.70% | 2.45 46.22% | 3.12 27.51% | 1.76 43.67% | 1.23 30.20% | 3.11 153.47% | 1.64 47.31% | 0.91 44.21% | -1.54 268.10% | |
net income per share | -0.71 - | -0.75 5.03% | -0.88 17.74% | -0.45 49.11% | -1.11 148.03% | -1.64 47.38% | -1.28 21.49% | -0.93 27.35% | -1.27 35.75% | |||
operating cash flow per share | -1.60 - | -1.47 7.63% | -1.39 5.44% | -0.94 32.26% | -1.10 16.03% | -1.67 51.98% | -1.21 27.48% | -0.90 25.22% | -1.22 34.66% | |||
payables turnover | ||||||||||||
receivables turnover | 2.02 - | 1.02 49.27% | 1.04 1.62% | 1.16 11.55% | 0.95 18.03% | 0.24 74.81% | 0.58 140.43% | 0.03 95.22% | 0.36 1,215.70% | 1.30 260.14% | ||
research and ddevelopement to revenue | 4.49 - | 4.96 10.57% | 4.03 18.77% | 2.34 41.81% | 4.10 74.87% | 9.90 141.38% | 4.83 51.21% | 63.76 1,220.35% | 11.55 81.88% | 4.97 57.02% | ||
return on tangible assets | -0.08 - | -0.11 26.04% | -0.15 43.49% | -0.15 0.68% | -0.24 57.69% | -0.43 80.88% | -0.54 26.25% | -0.23 57.74% | -0.41 78.68% | -0.47 14.82% | ||
revenue per share | 0.31 - | 0.33 7.13% | 0.49 48.49% | 0.60 23.50% | 0.42 29.98% | 0.16 62.97% | 0.30 91.17% | 0.01 96.31% | 0.11 875.05% | |||
roe | -0.12 - | -0.15 20.33% | -0.21 41.80% | -0.20 4.40% | -0.27 36.48% | -0.55 102.76% | -0.73 33.78% | -0.28 61.05% | -0.56 96.43% | -1.19 113.67% | ||
roic | -0.13 - | -0.15 19.81% | -0.21 36.34% | -0.20 4.12% | -0.27 34.76% | -0.53 93.96% | -0.70 32.61% | -0.22 67.75% | -0.53 135.85% | -0.70 32.63% | ||
sales general and administrative to revenue | 0.88 - | 0.81 8.64% | 0.64 21.00% | 0.34 46.15% | 0.63 82.39% | 1.41 125.19% | 0.64 54.38% | 22.85 3,448.20% | 2.66 88.36% | 1.06 60.14% | ||
shareholders equity per share | 5.88 - | 5.14 12.72% | 4.26 16.96% | 2.27 46.76% | 4.13 81.73% | 3.00 27.31% | 1.76 41.31% | 3.28 86.55% | 2.27 30.89% | |||
stock based compensation to revenue | 0.00 - | 0.01 1,792.63% | 0.01 1.07% | 0.33 2,274.77% | 0.10 68.10% | 0.26 148.54% | 0.20 22.84% | 2.52 1,154.12% | 0.50 80.25% | 0.18 63.44% | ||
tangible asset value | 57.01M - | 49.30M 13.52% | 40.39M 18.06% | 33.65M 16.70% | 62.20M 84.86% | 60.05M 3.46% | 40.16M 33.12% | 110.28M 174.57% | 88.10M 20.11% | 44.91M 49.02% | ||
tangible book value per share | 5.68 - | 4.92 13.52% | 4.03 18.06% | 2.14 46.91% | 4.01 87.48% | 2.92 27.07% | 1.71 41.59% | 3.26 90.64% | 2.25 30.91% | |||
working capital | 10.58M - | 15.97M 50.90% | 20.87M 30.71% | 32.65M 56.44% | 58.43M 78.96% | 56.55M 3.21% | 35.01M 38.09% | 119.09M 240.16% | 92.72M 22.14% | 75.68M 18.38% |
All numbers in (except ratios and percentages)